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INTRODUCTION
Transmission of signals at chemical synapses is accomplished
by regulated release of neurotransmitters from secretory
vesicles that have accumulated near the presynaptic membrane
of the axon terminal. There are three main types of secretory
vesicles, which carry different classes of neurotransmitters and
are represented in different proportions in diverse types of
neurons and neuroendocrine cells. Synaptic vesicles (SVs) or
synaptic-like microvesicles (SLMVs) in neuroendocrine cells
transport non-peptide neurotransmitters, large dense-core
vesicles (LDCVs) or secretory granules (SGs) in
neuroendocrine cells store neuropetides and biogenic amines,
whereas small dense-core vesicles (SDCVs) carry biogenic
amines alone. These types of vesicles share a number of
common membrane constituents, although they differ
considerably in their biogenesis (Huttner et al., 1995; Winkler,
1997). 
Biogenesis of SDCVs is poorly understood (Winkler, 1997).
Most likely, however, they are thought to be ‘hybrid’ vesicles
assembled from components of SVs and LDCVs in early
endosomes (Huttner et al., 1995). Mature LDCVs are formed
from immature secretory granules, which originate directly
from TGN. Thus, LDCVs are delivered to the terminal fully
assembled. In contrast, individual constituents of the SVs are
transported from TGN to the plasma membrane at the neurite
terminal by a constitutive pathway as components of precursor
organelles. After endocytosis, followed by sorting and budding
from early endosomes, they become components of mature
SVs, which undergo multiple rounds of recycling at the active
presynaptic terminal (Kelly and Grote, 1993; Rothman, 1994;
Südhof, 1995; Calakos and Scheller, 1996; De Camilli and
Takei, 1996). 
It is believed that SVs precursor organelles are delivered to
the terminals by microtubule-based fast anterograde transport
(Goodson et al., 1997; Hirokawa, 1998). However, precise
itineraries of various components of SVs remain unclear and
may vary. Several reports indicate that protein components of
the presynaptic terminal are already sorted in the cell body into
different classes of transport organelles and are delivered to
the assembly site at the terminal by specific motor proteins.
For instance, synaptic vesicle proteins synaptotagmin,
synaptophysin, and SV2 expressed in non-neuronal cells are
sorted independently into different cellular compartments
(Feany et al., 1993). Moreover, synaptotagmin, synaptophysin,
and Rab3A are sorted into a different class of precursor
organelles and are transported to the nerve terminals by
different motor proteins, and probably, via different routes than
SV2 and certain components of the presynaptic plasma
membrane. These differential modes of transport may reflect
the functional differences between the various synaptic
components (Okada et al., 1995). 
Direct comparison of the primary sequences of synaptic
vesicle proteins does not reveal any motif that could serve as
a universal targeting signal. This may indicate that each protein
component of SVs is delivered to the assembly site by a distinct
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We have investigated structural elements that determine
the accumulation of synaptotagmin, a major synaptic
vesicle protein, in neurite terminals of neuronally
differentiated neuroendocrine pheochromocytoma PC12
cells. We performed extensive deletion and point
mutagenesis of rat synaptotagmin II, expressed mutant
proteins in PC12 cells differentiated by nerve growth factor
(NGF) and monitored their intracellular distribution by
immunofluorescence. We found a structural element
located at the carboxy-terminal domain of the
synaptotagmin molecule, which is necessary for its
accumulation at the terminal. Using alanine-scanning
mutagenesis, we have identified two amino acids in this
element, tryptophan W405 and leucine L408, that are
critical for correct targeting of synaptotagmin II to neurite
terminals. Changing either one of them to alanine prevents
the accumulation of the protein at the terminals. These
amino acids are evolutionarily conserved throughout
the entire synaptotagmin family and also among
synaptotagmin-related proteins, suggesting that different
synaptotagmins may have similar mechanisms of targeting
to neuronal cell terminals.
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specialized transport system. Alternatively, it is possible that
each of the general transport systems interacts with several
different species of synaptic protein cargo. Finally, targeting
motifs may be present in only certain proteins, which then
serve to direct several other assembled protein components of
the precursor organelle to their destination. 
We sought to identify targeting signals in synaptotagmins,
which are obligatory constituents of SVs and LDCVs in
neurons and their analogs in neuroendocrine cells.
Synaptotagmins are multifunctional components of the
regulatory secretory machinery in neuronal cells involved
in exo- and endocytosis (Südhof, 1995; Südhof and Rizo,
1996; Geppert and Südhof, 1998; Schiavo et al., 1998).
Synaptotagmins are a large family of integral type I membrane
proteins identified to date in a wide spectrum of vertebrate and
invertebrate species and represented in mammals by at least
twelve distinct genes. Synaptotagmins are enriched in neurons
and neuroendocrine cells. Some synaptotagmin isoforms are
neuronal-specific, although their distribution in the nervous
system is isoform-specific. Other isoforms are expressed
ubiquitously. Synaptotagmins are structurally conserved and
possess several domains (Perin et al., 1990, 1991a,b; Fig. 1A).
A short amino-terminal N-glycosylated intravesicular domain
is followed by a single transmembrane domain and extended
cytoplasmic region. A large part of the C-terminal region
contains a tandem region of the Ca2+-regulatory C2A and C2B
domains separated by a short linker domain. A stretch of
charged amino acids (charged domain) connects the C2A
domain with the transmembrane domain. The C2B domain
is followed by a short carboxy-terminal domain. The C2
domains, which mediate Ca2+-dependent membrane fusion,
and the carboxy-terminal domain, for which no apparent
physiological function has been described, show a remarkable
degree of evolutionary conservation within different
synaptotagmin isoforms and different organisms. This suggests
that these domains may be involved in crucial protein-protein
interactions. Indeed, synaptotagmins form numerous
complexes with components of the synaptic vesicle and with
cytoplasmic and plasma membrane proteins (Südhof and Rizo,
1996; Schiavo et al., 1998; Geppert and Südhof, 1998). These
complexes may be important both for the functioning of the
synaptic vesicle at the neuronal cell terminal, and for its
delivery there. 
To examine the signals that are required to target a protein
molecule to the terminals of cultured neuronal cells, we tested
the distribution of tagged recombinant synaptotagmin II
molecules in neuroendocrine rat adrenal medula derived
pheochromocytoma PC12 cells (Greene et al., 1987),
neuronally differentiated after treatment with nerve growth
factor (NGF). PC12 cells synthesize most membrane proteins
that participate in regulated secretion in neurons, and contain
at least two types of secretory vesicles, acetylcholinergic
SLMVs and catecholaminergic and peptidergic secretory
vesicles (Cutler and Cramer, 1990; Clift-O’Grady et al., 1990;
Bauerfeind et al., 1993; Marxen et al., 1997). In this aspect,
PC12 cells are similar to the adrenergic sympathetic neurons,
which originate from the same precursor. After treatment with
NGF, PC12 cells develop extended neurites, which resemble
axons more than dendrites. In particular, neurite terminals and
varicosities of PC12 cells are enriched with both types of
secretory vesicles (Lah and Burry, 1993; Elferink et al., 1993;
Hudson et al., 1993). Furthermore, similar to axons, neurites
of PC12 cells are devoid of ribosomes, enriched with growth
cone-specific protein GAP43, and depleted of dendrite-specific
protein MAP2. In addition, axon-specific tau and MAP1
proteins are induced in these cells before extension of neurites
(for ref. see Kelly and Grote, 1993; Bonzelius et al., 1994). 
Here we demonstrate that a distinct element located in the
carboxy-terminal domain of the synaptotagmin molecule is
necessary for its proper targeting to the neurite terminal.
Mutations in this area prevent accumulation of the protein at
the terminal; in particular, two amino acids are absolutely
essential for correct targeting. These two indispensable amino
acids are evolutionarily conserved among all known
synaptotagmin isoforms and synaptotagmin-related proteins,
and may represent the crucial points of contact with the
transport machinery of neuronal cell.
MATERIALS AND METHODS 
Antibodies
Monoclonal antibodies (mAb) directed against influenza virus
hemagglutinin epitope (anti-HA, clone 12CA5; Field et al., 1988)
were purified from mouse ascite fluid on a low-salt Protein A-
Sepharose 4B (Sigma) column as described (Harlow and Lane, 1988).
Mouse mAb against rat synaptotagmin I (clone 41.1; Brose et al.,
1992) were a gift from Reinhard Jahn (Yale University School of
Medicine). Mouse anti-synaptophysin (clone SVP-38) and anti-
syntaxin 1a (clone HPC-1) mAb were obtained from Sigma. Sheep
anti-mouse biotinylated Ig, streptavidin-horseradish peroxidase
conjugate, and streptavidin-Texas Red conjugate were purchased from
Amersham. 
Plasmid constructions
Standard molecular cloning procedures were as described (Maniatis
et al., 1989). Plasmid pCMV65-8 containing a 2.7 kb EcoRI/XbaI
insert of the full-length rat synaptotagmin II cDNA (Geppert et al.,
1991) was a gift from Thomas Südhof (University of Texas,
Southwestern Medical Center at Dallas). Using appropriate restriction
sites and short PCR-generated fragments, the synaptotagmin II coding
region was recloned into a pUC19-based eukaryotic expression vector
pRSV containing 0.55 kb of the RSV promoter/enhancer region and
2.3 kb sequence of the rabbit b -globin gene fragment bearing
splicing/polyadenylation signal sites. The carboxy terminus of the
synaptotagmin II was fused with two copies of the influenza virus
hemagglutinin (HA) epitope (Field et al., 1988). In this fusion
construct (Syt-HA), the stop codon of synaptotagmin II was
omitted, and the 5 ¢ -untranslated region (115 bp) was left
unchanged. The structure of the 39 amino acids tag fragment was
LEASPPSSYPYDVPDYASLGGPSSYPYDVPDYASLGGPS. This
sequence is followed by two stop codons preceding the b -globin gene
fragment. A chain-breaking PP motif was used to connect the tag to
the rest of the protein; the sequence LEAS represents neighboring
unique XhoI/NheI restriction sites. 
Syt-HA subclones with random carboxy-terminal truncations of
synaptotagmin were generated essentially as described (Lin et al.,
1985). In the presence of Mn2+, SytII-HA-containing plasmid DNA
was subjected to DNase I treatment limited by single-cut cleavage.
DNA was cleaved at a NheI site, and after filling in with Klenow DNA
polymerase, was self-ligated. Prior to E. coli cells transformation,
DNA was treated at XhoI site to abolish the background of original
molecules. Subclones were analyzed using PCR-based bacteria
colonies screening and DNA sequencing. Syt-HA-based constructs
with directed carboxy terminus synaptotagmin deletions and
constructs with deletions of internal synaptotagmin fragments were
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prepared using convenient restriction sites and short PCR fragments
generated from synthetic primers. Similarly, alanine-scanning
mutagenesis was performed using PCR and primers containing the
desired mutations. The structure of each clone generated with PCR
was confirmed by DNA sequencing.
Cell culture and transient expression
PC12 cells were obtained from Lloyd Greene (Columbia University)
and maintained as an early passage stock. Cells were grown on
collagen (Upstate Biotechnology)/poly-D-lysine (Sigma)-coated
plates in DMEM supplemented with heat-inactivated 10% calf and
5% horse sera (HyClone) in the presence of 100 U/ml penicillin and
100 U/ml streptomycin. For neuronal differentiation, cells were
treated with 50 ng/ml of 2.5S NGF (mouse) (Upstate Biotechnology)
5 days before and 2 days after transfection. For transient expression,
cells were transfected by electroporation. Cells were grown with or
without NGF to a density of 10-15 · 106 per 10 cm plate. All the
following steps were performed at room temperature (RT). After
harvesting at 1300 rpm for 10 minutes, cells were resuspended in fresh
medium to a final density of 6· 106 per ml for immunofluorescent
analysis, or 30· 106 per ml for biochemical experiments. 250 m l of cell
suspension was mixed in an 0.4 cm electroporation cuvette (Bio-Rad,
Hercules, CA) with 20-40 m g (500 m g/ml) of plasmid DNA (Qiagen
or CsCl purified) and electroporation was performed at 230 V, 960 m F
(Gene Pulser, Bio-Rad). The cell suspension was then transferred
from the cuvette to a centrifugation tube preloaded with 20 ml of
medium. After harvesting, the cells were resuspended in an
appropriate volume of the medium with or without NGF and plated
on 3.5 cm plates supplemented with collagen/poly-D-lysine-coated
coverslips for immunofluorescence analysis or on 10 cm coated plates
for biochemical experiments (0.75 · 106 or 7.5 · 106 per plate,
respectively). For subsequent analysis, cells were used in 2 days.
Routinely, the efficiency of transfection was 10-15%.
Subcellular fractionation
Transfected NGF-differentiated PC12 cells (30· 106) were rinsed
twice with PBS at RT, dislodged from the plates by scraping into 10
ml of the cold homogenization buffer (0.2 M sucrose, 50 mM NaCl,
2 mM EGTA, 10 mM Tris-HCl, pH 7.4) supplemented with protease
inhibitors (PI; 1 m g/ml aprotinin, 1 m g/ml leupeptin, 1 m g/ml pepstatin,
1 mM PMSF), and pelleted at 32,500 g (20,000 rpm) for 20 minutes
(JA20 rotor). The pellet was resuspended in 2.0 ml of the
homogenization buffer and homogenized with a motor-driven Teflon-
glass homogenizer (700 rpm, 20 strokes). The centrifugation was
performed at 1000 g (3500 rpm, Eppendorf) for 10 minutes, and 1 ml
of post-nuclear supernatant was loaded on the top of a 12 ml linear
sucrose density gradient (0.2-2.3 M) containing 50 mM NaCl, 2 mM
EGTA and 10 mM Tris-HCl (pH 7.4). The centrifugation was
performed at 38,000 rpm (178,200 gAV) for 15 hours (SW 41.1 rotor,
Beckman); 0.5 ml fractions were collected from the bottom of the
tubes.
SDS-PAGE samples preparation and protein determination
Subcellular fractions or whole cell suspensions were aliquoted and
stored at - 80°C. Aliquots were mixed with an equal volume of 2 ·
SDS-buffer (4% SDS, 120 mM Tris-HCl, pH 6.8) supplemented
with PI. To disrupt DNA, lysates were passed three times through a
26-gauge needle. Then, samples were boiled for 4 minutes and
centrifuged at 15,000 rpm for 5 minutes at RT. Protein determination
was performed using BCA reagent system (Pierce). When necessary,
the assay was performed with DTT-containing samples. To avoid
DTT influence, before the assay, samples were subjected to
quantitative precipitation with 10 · excess of n-butanol in the
presence of glycogen (Boehringer Mannheim) as a carrier.
Precipitates were washed twice with acetone and dissolved in
desired volume of 100 mM NaOH. For sodium dodecylsulfate gel
electrophoresis (SDS-PAGE), lysats were mixed with 1/3 volume of
50% glycerol containing DTT (150 mM finally) and Bromophenol
Blue and boiled for 4 minutes.
SDS-PAGE immunoblotting 
SDS-PAGE was performed on 8.5% or 12.5% polyacrylamide gels.
After equilibration for 15 minutes in transfer buffer (48 mM Tris, 39
mM glycine, 0.0375% SDS, 20% methanol, pH 9.2; Harlow and Lane,
1988), proteins were transfered from the gel to the Immobilon-P
membrane (Millipore) using a semi-dry blotting system (Bio-Rad) for
1.5 hours at 15 V. Then, the membrane was washed 3· 10 minutes
with PBS and blocked overnight with 5% non-fat dry milk in PBS at
4o C. All the following steps were performed at RT. The membrane
was washed 3 · 10 minutes with PBS and incubated for 1 hour with
mAb (dilution 1:400 for anti-HA or 1:1000 for anti-synaptotagmin,
anti-synaptophysin, and anti-syntaxin) in PBS-T-BSA (PBS, 0.05%
Tween-20, 1% BSA) in the presence of 1% normal sheep serum
(Sigma). The membrane was next rinsed twice and washed 3· 10
minutes with PBS-T (PBS, 0.05% Tween-20), and incubated for 1
hour with sheep anti-mouse biotinylated Ig (dilution 1:1000) in PBS-
T-BSA. Then, the membrane was washed as above and incubated for
1 hour with streptavidin-horseradish peroxidase conjugate (1:1000
dilution) in PBS-T-BSA. After washing with PBS-T, the membrane
was rinsed with PBS and reactive bands were detected using ECL
system (Amersham). 
Immunofluorescence staining
Cells transfected with synaptotagmin-HA encoding constructs or non-
transfected cells were stained with anti-HA or anti-synaptotagmin
mAb, respectively. Cells were fixed on coverslips with 4% methanol-
free formaldehyde (Polysciences) in PBS for 20 minutes, washed 3·
10 minutes with PBS-G (PBS, 100 mM glycine) at RT, permeabilized
for 10 minutes with 0.1% Triton X-100 in PBS-G at 0°C, washed 3 ·
10 minutes with PBS, and incubated for 30 minutes in PBS-T-BSA
containing 1% normal sheep serum. Then cells were incubated for 1
hour in the same solution with mAb (dilution 1:50 for anti-HA or
1:100 for anti-synaptotagmin), washed 3 · 10 minutes with PBS-T and
10 minutes with PBS-T-BSA, and incubated for 1 hour in the same
solution with sheep anti-mouse biotinylated Ig (dilution 1:100). For
control of background staining, mAb were omitted or anti-HA mAb
were applied to non-transfected cells. After washing as above, cells
were incubated for 1 hour with streptavidin-Texas Red (dilution
1:100) in PBS-T-BSA, and washed 3 · 10 minutes with PBS-T and 2 ·
10 minutes with PBS. Coverslips were rinsed with water and mounted
with Gel/Mount medium (Biomeda). Cells were analyzed by two
observers independently with a Zeiss Axiophot fluorescence
microscope equipped with a · 40 Plan-Neofluar objective and
photographed using Kodak T64 color slide film. For each transfected
construct, over 25 images from at least 3 separate transfection
experiments were obtained. Representative images were processed
with Nikon Coolscan slide scanner and assembled with Adobe
Photoshop. For quantitative analysis, cell images were processed
using Scion Image. For each image (10 images per case), the average
pixel intensities of the terminals (T), the cell body (C), and of the
background (B) were measured, and the average ratio R = (T- B)/(C-
B) was calculated. 
RESULTS
Recombinant synaptotagmin is correctly targeted in
transfected PC12 cells
Synaptotagmins have a highly specific distribution in neurons,
and the highest concentrations are observed at the axon
terminals (Matthew et al., 1981; Matteoli et al., 1991;
Wendland et al., 1991; Ramaswami et al., 1994) and also in the
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region of the Golgi complex (Matteoli et al., 1991; Hou et al.,
1997). In neuronally differentiated PC12 cells, synaptotagmin-
specific antibodies recognize proteins with a similar
distribution (Elferink et al., 1993; Marxen et al., 1997), and
most of the immunoreactivity with anti-SytI mAb (clone 41.1;
Brose et al., 1992) was observed at the terminals and
varicosities of extended neurites and in the region of the Golgi
complex (Fig. 1B,a). 
To test whether recombinant synaptotagmin has a
comparable distribution and to discriminate it from
endogenous synaptotagmin, we prepared cDNA construct
coding for rat synaptotagmin II (Geppert et al., 1991) tagged
with HA-epitopes (Field et al., 1988). In this construct (Syt-
HA), two copies of the HA-epitope were fused to the carboxy
terminus of synaptotagmin II (Fig. 1A). In total, 39 amino acids
were added to the full-length (422 amino acids) synaptotagmin
II. This chimeric cDNA was placed under the control 
of the RSV promoter, and recombinant construct was
introduced by electroporation into PC12 cells neuronally
differentiated by NGF. The cellular distribution of recombinant
tagged synaptotagmin molecules was monitored by
immunofluorescence after incubation with anti-HA mAb.
Since the time required for full differentiation of PC12 cells
after addition of NGF (7-10 days) is much longer than the
time required for optimal expression of the transfected
synaptotagmin gene (2-3 days; data not shown), we used
primed PC12 cells that had undergone NGF treatment for 5-6
days before transfection (Greene et al., 1987). When such cells
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Fig. 1. Expression and intracellular localization of recombinant synaptotagmin in PC12
cells. (A) Synaptotagmin domain structure and schematic representation of the carboxy-
terminal rat synaptotagmin II fusion construct with HA-epitopes, Syt-HA. Domains are
numbered according to Südhof and Rizo (1996); rat synaptotagmin II domain borders are
mapped according to Geppert et al. (1991). (B) Immunofluorescence staining of NGF-differentiated PC12 cells: (a) non-transfected cells
labeled with anti-SytI mAb (41.1); (b) cells transfected with Syt-HA and labeled with anti-HA mAb (12CA5) 48 hours after transfection.
Similar images were captured from at least 10 (a) and 25 (b) other cells. Bar, 25 m m. (C) Expression of Syt-HA: SDS-PAGE immunoblotting of
whole cell SDS-lysates of non-differentiated PC12 cells. An equal amount of total protein from transfected and control non-transfected cells
was loaded (10 m g/lane); 8.5% PAGE: (a) anti-SytI mAb (41.1); (b) anti-HA mAb (12CA5). Note that none of the anti-HA reactive bands are
recognized by anti-Syt I mAb (41.1), indicating that these antibodies are highly selective for synaptotagmin I and do not cross-react with
synaptotagmin II.
kDa kDa
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were detached from the substrate, subjected to electroporation,
and replated in the presence of NGF, they restored neurites
within a very short time, and after 2-3 days, most of the cells
(>90%) had multiple branched extended neurites and
were indistinguishable from cells that have been exposed to
NGF continuously for 7-9 days. Likewise, the distribution of
endogenous synaptotagmin molecules in primed cells was the
same as in regular neuronally differentiated PC12 cells (data
not shown). This approach enabled us to combine the
neuronally differentiated status of PC12 cells with the high
level of expression of recombinant synaptotagmin. When
primed PC12 cells were transfected with the Syt-HA construct
and labeled with anti-HA mAb (Fig. 1B,b), staining revealed
a highly specific distribution of the tagged protein, with strong
enrichment in neurite terminals and varicosities. Except for the
terminals, neurites themselves were usually poorly stained.
Noteworthy, the length of the processes did not affect the level
of enrichment of immunoreactivity in the terminals. In the cell
bodies, most of the immunoreactivity was concentrated in the
region of the Golgi complex, whereas other parts of the
cytoplasm were less stained, and the cell nuclei were free of
HA-immunoreactivity. Preferential accumulation of Syt-HA
molecules at the terminals was further confirmed by confocal
microscopy of transfected cells (data not shown), and the
overall staining pattern was found to be similar to the
distribution of endogenous synaptotagmin I in non-transfected
differentiated PC12 cells (Fig. 1B,a). These visual assessments
are supported by the results of quantitative image analysis.
From the analysis, the mean ratio R of the average pixel
intensities of the terminals to the average pixel intensities of
the cell bodies was 1.79 (s.e.m. = 0.06) for the cells transfected
with Syt-HA and stained with anti-HA antibodies, and 1.55
(s.e.m. = 0.06) for the non-transfected cells stained with anti-
SytI antibodies for endogenous synaptotagmin. These values
are comparable, although the difference between them is
statistically significant (P<0.01; unpaired t-test).
To further study the expression of recombinant
synaptotagmin constructs, we prepared whole cell SDS-lysates
from PC12 cells transfected with Syt-HA and from non-
transfected control cells. Proteins were examined by
immunoblotting using anti-Syt I or anti-HA mAb (Fig. 1C, a
and b, respectively). Anti-Syt I antibodies recognized a diffuse
band of endogenous synaptotagmin I in both non-transfected
and transfected cells. The band had an apparent mobility of 60-
62 kDa and migrated more slowly in SDS-PAGE than its length
would predict, as described (Perin et al., 1991b). Uneven
distribution of charged residues along the synaptotagmin
molecule together with glycosylation (Perin et al., 1991b;
Geppert et al., 1991; Tugal et al., 1991) and fatty acylation
(Veit et al., 1996; Chapman et al., 1996) contribute to the
anomalous mobility of synaptotagmins in SDS-PAGE. When
lysates from Syt-HA-transfected cells were probed with anti-
HA antibodies, a major diffuse 70-72 kDa band, corresponding
to the HA-tagged synaptotagmin II molecule, was observed
(the change in mobility is due to the appended HA-epitope). In
addition, a less intensive band of 52 kDa was visible. This band
represents the cytoplasmic region of the protein and
corresponds to the major proteolytic fragment of Syt I
(positions 112-421) after cleavage of the hypersensitive site in
the charged domain (III) (Perin et al., 1991b; Tugal et al.,
1991). Two background bands of ~80 and ~48 kDa, which
were present in all lanes including lysates from non-transfected
cells, correspond to the endogenous anti-HA mAb-reactive
proteins. Since only a small fraction of cells was transfected
(routinely, 10-15%), these background proteins did not
contribute to the immunofluorescence signal. Thus,
immunoreactivity in the transfected cells is due to the correct
form of the tagged synaptotagmin molecule. Identical results
were obtained when SDS-lysates from NGF-differentiated and
naïve cells were analyzed after transfection with Syt-HA
construct (data not shown), suggesting that differentiation
status does not affect expression and stability of recombinant
synaptotagmin fusion molecules. 
When the HA-epitopes were located at the amino terminus
of the recombinant protein (HA-Syt version), protein was
expressed at much lower levels than the Syt-HA protein (data
not shown), suggesting that extension of the synaptotagmin
amino terminus with HA-epitopes leads to decreased stability
of such a protein. Its distribution did not resemble that of
endogenous synaptotagmin and the Syt-HA version. In this
case, anti-HA immunoreactivity was rather diffusely
distributed over the entire cell bodies, but was not detected at
the tips of the neurites (data not shown). 
Thus, expression, processing, and distribution of the
carboxy-terminal (but not amino-terminal) fusion of
synaptotagmin II with HA-epitopes accurately reflect the fate
of endogenous synaptotagmin molecules in PC12 cells. We
conclude that this system is adequate for studying structural
elements of the synaptotagmin molecule, which may account
for its accumulation at neurite terminals.
Carboxy-terminal domain is necessary for the
accumulation of synaptotagmin at neurite terminals
We have generated an extensive series of random truncations
of the synaptotagmin portion of the Syt-HA, extending from
the carboxy-terminal domain to the intravesicular domain.
Of the 92 subclones analyzed, 29 contained truncated
synaptotagmin sequences in frame with the HA-epitope.
Sixteen deletion variants evenly covering the entire
synaptotagmin molecule (Fig. 2A) were introduced into PC12
cells for immunofluorescence and immunoblotting analyses.
Fig. 2B shows a SDS-PAGE immunoblotting of lysates of
PC12 cells transfected with truncated Syt-HA mutants after
incubation with anti-HA antibodies. Almost all constructs with
deletions covering the carboxy-terminal, C2B, C2A, and the
charged domains (VII, VI, IV, and III) were expressed at high
levels and produced polypeptides of the expected length.
However, when truncations covered domain III, the proteins
were less stable. The shortest constructs (82 D 340 and 45D 377)
with truncations extending to the transmembrane domain (II)
and the intravesicular domain (I) were unstable and produced
only faint low-molecular weight bands. Most of the longer
constructs contained an additional band (52 kDa for Syt-HA
full-length, 422 wt) resulting from the cleavage of the
hypersensitive proteolytic site in the charged domain.
Furthermore, constructs in which truncations were terminated
in the carboxy-terminal domain (D 27) or the upstream C2B
domain (D 179 and further), but not within C2B (D 69-D 150),
produced additional polypeptides with lower mobility resulting
from yet another unidentified cleavage site(s) (see also below). 
Fig. 2C shows representative examples of neuronally
differentiated PC12 cells transfected with HA-tagged full-
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length and truncated variants of
Syt-HA and stained with anti-HA
antibodies. Full-length protein (422
wt) was accumulated in the tips and
varicosities of the neurites (a), as
described above. However, deletion
of as few as 27 amino acids from
the carboxy terminus of the
synaptotagmin portion of the fusion
protein (construct 395 D 27) blocked
its accumulation at neurite terminals
and varicosities, although the pattern
of staining of the cell bodies was not
changed (b). In this case, the value of
the mean ratio (R) of the average
pixel intensities of the terminals to
the average pixel intensities of the
cell bodies was 0.29 (s.e.m. = 0.03)
compared with 1.79 (s.e.m. = 0.06)
for full-length protein. Such a
difference (about 6 fold) is
statistically significant (P<0.001;
unpaired t-test) and thus supports our
assessments based on the visual
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Fig. 2. Synaptotagmin carboxy-terminal
truncation mutants: expression and
intracellular localization in PC12 cells.
(A) Schematic representation of Syt-HA
subclones with random truncations of
synaptotagmin II carboxy terminus.
(B) Expression of Syt-HA truncated
subclones. SDS-PAGE immunoblotting
of whole cell SDS-lysates of transfected
and control non-differentiated PC12
cells; anti-HA mAb. An equal amount of
total protein was loaded (10 m g/lane):
(a) 8.5% PAGE; (b) 12.5% PAGE.
(C, a,b,c) Immunofluorescence staining
of NGF-differentiated PC12 cells
transfected with Syt-HA truncated
subclones and labeled with anti-HA
mAb. In each case, similar images were
captured from over 25 other cells in at
least 3 independent experiments. Bar,
25 m m. 
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analysis of large number of cells transfected with this and other
constructs (see below). 
Progressive truncation of the sequences containing
fragments of C2B and C2A domains did not result in any
further noticeable changes in the distribution of the
recombinant protein in the cells (Fig. 2C, c, and data not
shown) in comparison with construct 395D 27. A similar
pattern was revealed when the truncations were extended to the
charged and the transmembrane domains (data not shown),
although in this case, the staining may reflect the distribution
of degradation fragments (Fig. 2B,b). 
These data strongly indicate that determinants required for
the accumulation of synaptotagmin to the neurite terminals are
located in the carboxy-terminal domain of the molecule. To
further examine the constructs that do and do not contain the
carboxy-terminal targeting determinants, we performed
subcellular fractionation of extracts from cells transfected with
the full-length construct Syt-HA (422 wt) and one of its
truncated variants (319D 103). This truncated mutant lacks 103
amino acids from the carboxy terminus and does not
accumulate at the neurite terminals (Fig. 2C,c); the difference
in length between the full-length and truncated variants permits
their separation by SDS-PAGE and subsequent simultaneous
detection by immunoblotting. To ensure identical conditions
for fractionation of both versions of Syt-HA, we transfected
PC12 cells with 422wt and 319D 103 constructs separately,
mixed the cells together, and plated. After disrupting this
mixed population of cells and centrifuging at low speed,
organelles from the post-nuclear supernatant were separated on
a 0.2-2.3 M linear sucrose density gradient and gradient
fractions were analyzed by immunoblotting with antibodies
against HA-epitope, synaptotagmin I, synaptophysin, and
syntaxin 1a (Fig. 3).
Endogenous synaptotagmin I, which is present in both
SLMVs and in the secretory granules (Trifaro et al., 1989;
Perin et al., 1991b; Schmidle et al., 1991; Walch-Solimena et
al., 1993; Bonzelius et al., 1994), sedimented as a broad band
after centrifugation, reflecting its bimodal distribution,
Fig. 3. Subcellular fractionation of transfected NGF-differentiated PC12 cells. Two cell pools were separately transfected with full length SytII-
HA (wt) and its carboxy terminus truncated variant 319 D 103, mixed together and plated. After 48 hours, a post-nuclear supernatant was
prepared and subjected to linear sucrose density gradient (0.2-2.3 M) fractionation. Gradient fractions were examined with SDS-PAGE
immunoblotting (8.5% PAGE) using anti-HA (12CA5), anti-synaptotagmin I (41.1), anti-synaptophysin (SVP-38), and anti-syntaxin 1a (HPC-
1) mAb. An equal volume from each fraction was loaded. Fractions are numbered from the top to the bottom of the gradient. Immunoblots were
scanned and analyzed using Scion Image. The amount of proteins in each fraction is expressed as a percentage of their total amount in all
fractions. Density of fractions was determined by refractive index. Density of fractions containing maximum immunoreactivity of
synaptophysin was 1.12 g/cm3; of synaptotagmin I, 1.12 g/cm3; and of both recombinant HA-tagged synaptotagmin II and its truncated mutant,
1.13 g/cm3.
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although its main portion was located in more dense fractions
(with the maximum at 1.15 g/cm3) most likely containing
secretory granules in accordance with earlier results (Schmidle
et al., 1991; Bonzelius et al., 1994). Synaptophysin, which
marks SLMVs (Clift-O’Grady et al., 1990; Walch-Solimena et
al., 1993) as well as endosomes, migrated in a zone on the less
dense shoulder of the synaptotagmin peak (with the maximum
at 1.12 g/cm3). A small portion of synaptophysin was also
present in more dense fractions reflecting the presence of a low
amount of synaptophysin in secretory granules of PC12 cells
(for discussion see Winkler, 1997). Syntaxin was present in a
broad zone across the gradient reflecting its association with
both vesicles and plasma membranes (Walch-Solimena et al.,
1995). Recombinant HA-tagged synaptotagmin II and its
truncated mutant migrated in the same zone of the gradient as
the endogenous synaptotagmin I. However, their content was
higher in the zone of less dense fractions with the maximum
at 1.13 g/cm3, suggesting that both recombinant synaptotagmin
variants were mostly associated with SLMVs or their
precursors, rather than with secretory granules. No
recombinant synaptotagmin was revealed in fractions of
soluble proteins on the top of the gradient. It is also notable
that the fractions with characteristic densities corresponding to
the rough endoplasmic reticulum (1.18-1.26 g/cm3; Spector et
al., 1998) were substantially depleted of immunoreactivity of
both wt and mutant recombinant synaptotagmins. Importantly,
there was no difference in the distribution of the full-length and
the truncated versions of Syt-HA, despite the fact that only the
full-length protein, but not the truncated version, is correctly
targeted to the neurite terminals.
These results indicate that both versions are incorporated
into similar membrane organelles, and suggest that
accumulation of the mutant form in the terminals is blocked
not due to retention of newly synthesized protein molecules in
the rough endoplasmic reticulum, but due to later events. This
notion is also supported by the results of the immunostaining
analysis showing that for both versions the staining of the cell
bodies was concentrated mainly in the region of the Golgi
complex whereas other parts of cytoplasm were usually less
stained (Fig. 2C,a,c). This suggests that carboxy-terminal
targeting determinants do not represent a sorting signal that
directs the synaptotagmin molecule to the vesicles or their
precursors. Therefore, they should be utilized by some other
mechanisms which determine synaptotagmin accumulation at
the neurite terminals. 
There are examples of proteins, including synaptotagmin-
related proteins, which are able to accumulate at the terminals
but do not possess transmembrane domains. Among them is
rabphilin-3A (Li et al., 1994) which shares extensive sequence
similarity with synaptotagmin. To address the question if
accumulation of synaptotagmin in the neurite terminals can be
achieved without association with membrane organelles, we
prepared a series of mutants with internal deletions in the
transmembrane and also in the charged regions (domains II
and III, respectively) (Fig. 4A). This area contains several
determinants that are potential targets for important
modifications and interactions, such as clusters of positively
and negatively charged residues, including a cluster of lysine
residues that can be a potential recognition site for proteases,
and a group of conserved cysteine residues that can be
substrates for palmitoylation. In addition, we prepared a mutant
lacking both C2 domains and the short linker between them
(domains IV, V, and VI).
When the expression of these constructs was tested by
immunoblotting, some of the mutant proteins demonstrated
faster mobility than was expected. Data in Fig. 4B indicate that
amino acids in transmembrane domain II and charged residues
in domain III contribute greatly to the abnormal mobility of
synaptotagmin in SDS-PAGE. When either one of these
domains (constructs 398 D 24(64-87), 383 D 39(49-87), and
372D 50(89-138)) or both of them (constructs 347D 75(64-138)
and 332D 90(49-138)) were removed, the mobility of
recombinant proteins dropped dramatically and corresponded
more closely to the predicted mobility (taking into account the
appended HA-epitope and the effects of post-translational
modifications). The immunoblotting results are also consistent
with the notion (see above) that in addition to the main
hypersensitive proteolytic site located in domain III, there may
be another site(s). When the deletion covered domains II
and III (construct 347D 75(64-138)) and thus the main
hypersensitive proteolytic site was removed, the HA-tagged
proteolytic fragment with mobility ~42 kDa was detected. The
mobility of this fragment was increased when the deletion was
extended to the 15 amino acids of the border of domain I
(construct 332 D 90(49-138)). This indicates the presence of a
proteolytic site(s) in the intravesicular domain upstream of
position 48. Fragments likely to have arisen from the same
origin were also detected when C2 domains were deleted
(construct 184 D 238(145-382)). The presence of a proteolytic
site in the intravesicular domain has already been suggested for
synaptotagmin I (Tugal et al., 1991; Wendland and Scheller,
1994).
Fig. 4C shows the distribution of the tagged proteins with
internal deletions in differentiated PC12 cells. When the large
deletion covered the charged domain, the transmembrane
domain, and the adjacent fragment of the intravesicular domain
(construct 332D 90(49-138)), the protein lost its ability to
accumulate at the neurite terminals (a). The same pattern was
revealed, when deletion was restricted by the borders of the
transmembrane and the charged domains (construct
347D 75(64-138); data not shown). The deleted region includes
conserved cysteine residues C90, C91, and C92 in the domain
III, which have been reported to undergo palmitoylation
(Chapman et al., 1996). Palmitoylation of proteins may be
important for intracellular trafficking (Rothman, 1994).
However, removal of these residues (construct 418D 4(89-92))
did not prevent transport of the protein to the terminals (d).
Moreover, removal of the entire domain III (construct
372D 50(89-138)) also did not affect targeting (e). At the same
time, when domain III was intact, but the transmembrane
domain was removed (constructs 398D 24(64-87) and
383D 39(49-87)), the proteins did not accumulate at the
terminals (b and c). When the entire C2A and C2B domains
(IV-VI), which constitute two-thirds of the synaptotagmin
molecule, were removed (construct 184D 238(145-382)), the
recombinant protein was still able to accumulate at the terminals
(f), indicating that these domains are not essential for targeting.
Thus, protein comprised of amino-terminal (domains I, II,
and III) and carboxy-terminal (domain VII) regions of the
synaptotagmin molecule can be correctly transported to the
terminals, suggesting that these regions are sufficient for
targeting.
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Fine mapping of the carboxy-
terminal region
Our data suggest that structural
elements in the carboxy-terminal
domain may determine the
accumulation of the synaptotagmin
molecule at neurite terminals. We
performed fine mapping of the
carboxy-terminal region using short
deletions and alanine scanning point
mutagenesis. As follows from
immunoblotting analysis, all proteins
carrying deletions and point mutations
were expressed at similar levels in
transfected cells and produced bands
of expected mobility (Figs 5A, 6A).
When mutants lacking 3, 6, and 12
amino acids from the synaptotagmin
carboxy terminus (constructs 419D 3,
416D 6, and 410 D 12) were tested by
immunochemistry (Fig. 5B,a,b,c),
their distribution was the same as that
of the full-length wild-type Syt-HA
(422 wt). However, when an additional
9 (construct 401 D 21) or more amino
acids were removed proteins lost their
preferential accumulation at the
terminals and varicosities (d,e, and
data not shown). These results
demonstrate that the last 12 amino
Fig. 4. Synaptotagmin mutants with internal
deletions: expression and intracellular
localization in PC12 cells. (A) Schematic
representation of Syt-HA subclones with
internal deletions of the transmembrane,
charged (domains II, III), and C2 regions
(domains IV-VI). (B) Expression of Syt-HA
subclones with internal deletions. SDS-PAGE
immunoblotting of whole cell SDS-lysates of
transfected and control non-differentiated PC12
cells; anti-HA mAb. An equal amount of total
protein was loaded (10 m g/lane); 8.5% PAGE.
(C,a-f) Immunofluorescence staining of NGF-
differentiated PC12 cells transfected with Syt-
HA subclones bearing internal deletions and
labeled with anti-HA mAb. In each case,
similar images were captured from over 25
other cells in at least 3 independent
experiments. Bar, 25 m m.
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Fig. 5. Fine mapping of the carboxy-terminal targeting
signal. (A) Schematic representation and immunoblotting
analysis of expression in PC12 cells of Syt-HA subclones
with small truncations of synaptotagmin carboxy terminus
( D 3- D 40 amino acids) and of the variant with internal
deletion 413 D 9(402-410). Equal amounts of total protein
from whole cell SDS-lysates of transfected non-
differentiated PC12 cells was loaded (10 m g/lane); 8.0%
PAGE; anti-HA mAb. (B,a-f) Immunofluorescence
staining of NGF-differentiated PC12 cells transfected with
Syt-HA subclones indicated above and labeled with anti-
HA mAb. In each case, similar images were captured from
over 25 other cells in at least 3 independent experiments.
Bar, 25 m m.
A
B
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acids of synaptotagmin II are dispensable, whereas the region
between amino acids 401 and 411 is necessary for the correct
targeting of the molecule to the terminal. When this short
stretch of amino acids was removed by an internal deletion
(construct 413 D 9(402-410)), the molecules did not accumulate
at the neurite terminals (f), supporting the notion that this
sequence (IAQWHSLKP) contains amino acids critical for the
targeting of synaptotagmin II to the terminals and may
represent a targeting signal.
Interestingly, expression of mutants that failed to accumulate
at the terminals (truncations D 21-D 40 and internal deletion D 9),
but not expression of other mutants ( D 3-D 12) or the wild type,
was accompanied by the appearance of fragments with
mobility 62-63 kDa (Fig. 5A), which likely arise from cleavage
in the proteolytic site(s) located in the domain I. The same
fragments were evident when cells were pretreated with 20%
TCA to diminish possible protein degradation during
preparation of whole cell lysates (data not shown) indicating
that cleavage may occur in vivo. This suggests that certain
mutations in the synaptotagmin carboxy terminus are able to
modify the sensitivity of the proteolytic site(s) in its amino
terminus. Appearance of these fragments may reflect increased
accessibility for the degradation of some mutant molecules that
are not able to reach their proper destinations at the terminals.
However, the presence of the proteolytic fragments cannot
greatly affect the results of the immunochemistry analysis
because the major immunoreactivity is represented by
uncleaved molecules. 
To identify the critical amino acid residues within the
carboxy-terminal targeting signal, we performed alanine
scanning point mutagenesis of the IAQWHSLKP region,
leaving the remaining portion of the Syt-HA protein intact.
When the panel of point mutants was tested by
immunochemistry (Fig. 6B), all but two of the constructs
displayed enrichment at the tips of neurites similar to the wild
type. In contrast, when tryptophan at position 405 (W405) or
leucine at position 408 (L408) were changed to alanine, the
proteins failed to accumulate at the neurite terminals (mutation
of histidine at position 406 also impaired accumulation at the
terminals but did not abolish it). Moreover, like other mutants
that failed to accumulate at the terminals (Fig. 5A), W(405)A
and L(408)A mutants, but not other constructs with point
mutations in this region, were found to display the presence of
the minor bands (~62-63 kDa) when tested by immunoblotting
(Fig. 6A). 
Thus, we conclude that W405 and L408 are indispensable
for the proper targeting of synaptotagmin II to the neurite
terminals. These two residues are absolutely conserved in all
known synaptotagmin isoforms (see below), further supporting
their crucial role as targeting determinants.
DISCUSSION
We have identified the structural elements of the molecule of
the synaptic vesicle protein synaptotagmin II that are required
for its targeting to the neurite terminals. Synaptotagmin
accumulation at the neurite terminals is dependent on the
carboxy-terminal domain (VII) of the protein, provided that the
region of the transmembrane domain (II) is intact. Disruption
of each of these elements prevents the correct distribution of
the protein, whereas the deletion of the remaining part of the
molecule (domains III, IV, V, and VI) has no effect. 
The importance of the transmembrane region suggests that
synaptotagmin must be incorporated into proper membrane
organelles in order to utilize vesicular transport machinery via
its carboxy-terminal domain. Interestingly, synaptic targeting
of the peripheral synaptic vesicle protein rabphilin-3A, which
lacks a transmembrane domain but shares extensive sequence
similarity with the carboxy-terminal domain of synaptotagmin,
is also dependent on association with a vesicle (via its
interaction with an obligatory constituents of synaptic vesicles
Rab3A and Rab3C) (Lin et. al., 1994). 
Within the carboxy-terminal domain of the synaptotagmin
molecule, we have identified a short stretch of amino acids
(IAQWHSLKP) that is critical for targeting and have shown
that two particular amino acids (W405 and L408) are
indispensable for this function. Converting either one of these
amino acids to alanine in the otherwise intact 422-residue
protein prevents the accumulation of the entire synaptotagmin
II molecule at the neurite terminals. This indicates that residues
W405 and L408 (and to a lesser degree H406) may be crucial
points of contact between the synaptotagmin molecule and the
cell components that determine its itinerary in the neuronal
cell. Noteworthy, when possible conformations of the
synaptotagmin II carboxy-terminal domain were modeled
using the Macromodel program (P. Nestler and P. Krasnov,
unpublished), these crucial residues fell within the loop of a
highly stable hairpin formed by the adjacent acidic and basic
residues. 
The notion that the carboxy-terminal domain of the
synaptotagmin molecule contains a structural element that may
determine protein accumulation at the terminals is further
supported by the analysis of the evolutionary conservation of
this region. Table 1 represents the alignment of carboxy-
terminal regions of all known synaptotagmin family members
and synaptotagmin-related proteins from evolutionarily diverse
species. It shows that carboxy terminus endings are not
conserved and vary greatly in length and sequence, although
the same isoforms of different species are more similar than
different isoforms of the same species. This agrees well with
our finding that the last 12 amino acids of the synaptotagmin
II carboxy terminus are not necessary for its targeting
functions. In contrast, the beginning and the middle parts of
the carboxy-terminal domain reveal a remarkable degree of
conservation. Within this conserved region, the sequence
WHXL is invariable in all tested species throughout the entire
synaptotagmin family and in synaptotagmin-related proteins
(the only found exception was rat synaptotagmin isoform Srg1
where leucine is conservatively replaced by valine). The fact
that the residues indispensable for targeting to the terminals are
entirely conserved in this protein group across species suggests
that the WHXL motif may serve as an actual targeting signal. 
In many transmembrane proteins, short cytoplasmic amino
acids motifs serve as sorting or targeting signals, which
determine specific itinerary of the protein in the cell
(Trowbridge et al., 1993; Rothman and Wieland, 1996).
However, for the obligatory components of synaptic vesicles
or secretory granules in neuronal cells, the data on the sorting
or targeting signals are limited. It has been reported that the
cytoplasmic domain of synaptophysin is necessary for the
endocytosis of this protein (Linstedt and Kelly, 1991). Various
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motifs have been shown necessary for endocytosis and/or
sorting to synaptic vesicles or secretory granules of VAChT
and VMAT (acetylcholine and monoamine transporters,
respectively; Tan et al., 1998; Varoqui and Erickson, 1998),
PAM (peptidyl-amidating monooxygenase; Milgram et al.,
1996) and VAMP (vesicle-associated membrane protein or
synaptobrevin; Grote et al., 1995; Grote and Kelly, 1996).
Furthermore, cytoplasmic domain of VAMP fused to
transferrin receptor was sufficient to target chimeric protein to
the axons of cultured hippocampal neurons, although the axon-
targeting determinants of VAMP cannot be localized within
any short amino acid motif, but are rather distributed along the
cytoplasmic region (West et al., 1997). 
There are several possible steps in the itinerary of synaptic
vesicle proteins where the difference between the wild-type
and mutant forms of synaptotagmin may determine whether the
molecule will accumulate at the terminal. For instance, it is
possible that the signal at the carboxy-terminal domain
determines initial sorting of the protein and its incorporation
into the correct membrane structures. The mutant forms may
then become incorporated in the organelles that are not
destined to be delivered to the neurite terminals. However, our
data indicate that the distribution of the full-length form of Syt-
HA, which is correctly targeted to the terminal, and of the
truncated variant lacking 103 amino acids, which does not
target correctly in a sucrose density gradient is similar. This
suggests that both forms may be sorted to the same precursor
organelles or vesicles and that the differences in their final
distribution may be due to later events.
It is also possible that accumulation of synaptotagmin at the
neurite terminals (and the failure of the mutant to do so) is due
to the retention of the protein or the entire precursor organelle
at the terminal. Such retention may be required before the
protein, which is delivered to the terminal in association with
a precursor organelle by fast anterograde transport, can be
incorporated into mature synaptic vesicles. This step may be
coupled with the discharge of the synaptotagmin-containing
cargo organelle from the anterograde transport system once
this organelle is delivered to the terminal by the motor proteins.
Depending on the kinetics of these steps, the retaining
molecule(s) at the nerve terminal need not necessarily be in
stoichiometric proportion to the synaptotagmin molecules and
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Fig. 6. Alanine scanning point mutagenesis of Syt-HA
synaptotagmin carboxy terminus. (A) Schematic
representation and immunoblotting analysis of expression in
PC12 cells of Syt-HA subclones with point mutations in the
IAQWHSLKP (402-410) region. Equal amount of total
protein from whole cell SDS-lysates of transfected non-
differentiated PC12 cells was loaded (10 m g/lane); 8.5%
PAGE; anti-HA mAb. (B,a-h) Immunofluorescence staining
of NGF-differentiated PC12 cells transfected with point
mutants of Syt-HA and labeled with anti-HA mAb. In each
case, similar images were captured from over 25 other cells in
at least 3 independent experiments. Bar, 25 m m.
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may be represented by a small number of protein molecules.
To date, synaptotagmin is known to interact with a number of
proteins. However, most of them, such as the components of
the multimeric synaptic docking and fusion complex syntaxin
(Chapman et al., 1995; Kee and Scheller, 1996), SNAP-25 and
b -SNAP (Schiavo et al., 1995, 1997), as well as SV2 (Schivell
et al., 1996), N-type and P/Q-type calcium channels (Sheng et
al., 1997; Charvin et al., 1997), and clathrin adaptor AP-2
(Zhang et al., 1994) bind to synaptotagmin via its C2A or C2B
domains. Synaptotagmin is also known to interact with
calmodulin (Trifaro et al., 1989). However, the calmodulin
binding site is located in the very beginning of the
synaptotagmin carboxy terminus sequence, and the WHXL
motif does not participate in this interaction (Perin et al., 1996).
Other proteins known to interact with synaptotagmin are
neurexins. They constitute a large polymorphic family of low
abundance plasma membrane proteins with the characteristics
of cell surface receptors. Neurexins are expressed in neuronal
Table 1. Carboxy-terminal sequences of species-specific synaptotagmin isoforms and related proteins
Alignment was performed using GCG PileUp. On the right, sequences accession numbers (NCBI). Conserved elements of mirror symmetry motifs (Perin,
1996) are highlighted. Tryptophan and leucine residues, which are critical for synaptotagmin II targeting, are in red. Proteins are named in accordance with
established nomenclature (Südhof and Rizo, 1996; Schiavo et al., 1998). Originally named rat and human synaptotagmins V (Craxton and Goedert, 1995; Hudson
and Birnbaum, 1995; Craxton et al., 1997) are referred to as synaptotagmins IX. The group of synaptotagmin-related proteins is represented by rabphilin-3A,
doc2 isoforms and B/K protein; according to BLAST analysis, hypothetical protein F37A4.7 is likely C. elegans specific isoform of rabphilin-3A. All these
proteins share sequence similarity with synaptotagmin and possess synaptotagmin-like domain structure, but lack a transmembrane-spanning domain. Rabphilin-
3A (Li et al., 1994) and closely related doc2 isoforms (Orita et al., 1995) are associated with peripheral membrane proteins of synaptic vesicles; membrane
anchoring is also suggested for B/K protein (Kwon et al., 1996). 
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and neuroendocrine cells and enriched at the nerve terminals
(Valtorta et al., 1984; Ushkaryov et al., 1992; Ullrich et al.,
1995). The precise biological function of neurexins is unclear;
however, they may be involved in synaptic neuron-neuron
interactions, and in the regulation of docking and
neurotransmitter release (Missler et al., 1998). Neurexins have
been reported to interact in vitro with various synaptotagmin
isoforms and also with synaptotagmin-related protein
rabphilin-3A (Surkova and Grishin, 1991; Petrenko et al.,
1991; Hata et al., 1993; Perin, 1994, 1996). Importantly, these
interactions occur via the carboxy-terminal domains of
synaptotagmin and rabphilin-3A (Perin, 1994, 1996).
Moreover, peptide-binding studies have demonstrated that the
crucial points of contact with neurexins in the synaptotagmin
and rabphilin-3A carboxytermini include the conserved
WHXL motif and its mirror image symmetry counterpart,
which resides at the beginning of the carboxy terminus
sequence (Perin, 1996; Table 1). Therefore, there is a
remarkable correlation between synaptotagmin residues that
are important for synaptotagmin-neurexin interaction and those
that were identified in our experiments as critical for targeting.
Thus, a plausible explanation for the targeting features of the
carboxy-terminal signal involves synaptotagmin-neurexin
interactions. It is possible that neurexin binds to
synaptotagmin-containing vesicles and facilitates their initial
retention, hence contributing to their eventual accumulation at
the terminals. 
Finally, it is possible that the carboxy-terminal targeting
signal determines the interactions of the synaptotagmin
molecule with the motor proteins involved in the fast
anterograde transport of the vesicles to the terminals, and that
mutations in the targeting signal compromise this binding.
Members of the recently identified kinesin superfamily appear
to be involved in the fast anterograde transport of different
organelles (Goodson et al., 1997; Hirokawa, 1998). Some of
them are neuronal specific and implicated in delivery to the
nerve terminal of precursor organelles loaded with different
components of plasma membrane and synaptic vesicles
including synaptotagmin (Okada et al., 1995; Amaratunga et
al., 1995; Hurd and Saxton, 1996). Importantly, these different
components are likely to be presorted before delivery and are
probably transported to the terminals as components of
different precursor vesicles. For instance, the presence of at
least two different types of transported precursor organelles
carrying different sets of proteins and employing different
motors has been shown (Okada et al., 1995). One type
contained synaptotagmin, synaptophysin, and Rab3A and was
associated with motor protein KIF1A, whereas another
contained SV2 and plasma membrane components (syntaxin 1
and SNAP-25) and was not associated with KIF1A. Moreover,
a sciatic nerve ligation experiment demonstrated abolition of
synaptotagmin, but not syntaxin 1, transport in KIF1A-
deficient mice (Yonekawa et al., 1998). Thus, it is conceivable
that mutations in the synaptotagmin carboxy terminus, which
prevent the delivery of the protein to the terminals, may act by
disrupting the interactions of synaptotagmin with a specific
kinesin-type motor molecule. 
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